AsianScientist (Jan. 13, 2014) – Zynex Medical, Inc. has signed a five-year agreement with DIH Medical Technologies Co Ltd to distribute its NeuroMove device in China.
The NeuroMove, a proprietary stroke rehabilitation device developed by Zynex, enables stroke patients to regain mobility, even several years post-stroke, through neuroplasticity, a method that facilitates relearning in parts of the brain to control and strengthen muscle function.
Zynex, a provider and developer of non-invasive medical devices for electrotherapy, stroke rehabilitation and neurological diagnosis, has received approval from the Chinese SFDA for its NeuroMove device.
“We are very excited to be working with DIH for the Chinese market due to their strong presence in the stroke rehab segment and their proven record of fast growth and market development,” said Thomas Sandgaard, president and CEO of Zynex.
DIH Medical Technologies has been distributing rehabilitation equipment in China for twenty years and has a strong presence in stroke rehabilitation.
——
Source: Zynex Medical Inc.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
